Clémentine Alitti, Agnès Rode, Hervé Trillaud, Philippe Merle, Jean-Frédéric Blanc, Lorraine Blaise, Alix Demory, Gisele Nkontchou, Véronique Grando, Marianne Ziol, Pierre Nahon, Nathalie Ganne-Carrié, Arthur Petit, Olivier Seror, Olivier Sutter, Jean-Charles Nault
INTRODUCTION: The effectiveness of percutaneous radiofrequency ablation (RFA) in intrahepatic cholangiocarcinomas (iCCA) remains insufficiently studied. METHODS: We conducted a retrospective study including patients with histologically proven iCCA within Milan criteria treated by percutaneous RFA from 2000 to 2022. The primary outcome was overall survival in treatment-naive patients and secondary outcomes included ablation completeness, adverse events, local and distant recurrence...
March 4, 2024: Liver International: Official Journal of the International Association for the Study of the Liver